Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb-Mar:99-100:67-70.
doi: 10.1016/j.jcv.2018.01.003. Epub 2018 Jan 11.

Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection

Affiliations

Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection

Susan H Eshleman et al. J Clin Virol. 2018 Feb-Mar.

Abstract

Background: Assays that detect HIV antigen (Ag) and antibody (Ab) can be used to screen for HIV infection.

Objectives: To compare the performance of the BioPlex 2200 HIV Ag-Ab assay and two other Ag/Ab combination assays for detection of acute HIV infection.

Study design: Samples were obtained from 24 individuals (18 from the US, 6 from South Africa); these individuals were classified as having acute infection based on the following criteria: positive qualitative RNA assay; two negative rapid tests; negative discriminatory test. The samples were tested with the BioPlex assay, the ARCHITECT HIV Ag/Ab Combo test, the Bio-Rad GS HIV Combo Ag-Ab EIA test, and a viral load assay.

Results: Twelve (50.0%) of 24 samples had RNA detected only ( > 40 to 13,476 copies/mL). Ten (43.5%) samples had reactive results with all three Ag/Ab assays, one sample was reactive with the ARCHITECT and Bio-Rad assays, and one sample was reactive with the Bio-Rad and BioPlex assays. The 11 samples that were reactive with the BioPlex assay had viral loads from 83,010 to >750,000 copies/mL; 9/11 samples were classified as Ag positive/Ab negative by the BioPlex assay.

Conclusions: Detection of acute HIV infection was similar for the BioPlex assay and two other Ag/Ab assays. All three tests were less sensitive than a qualitative RNA assay and only detected HIV Ag when the viral load was high. The BioPlex assay detected acute infection in about half of the cases, and identified most of those infections as Ag positive/Ab negative.

Keywords: Acute; Ag/Ab assay; BioPlex; HIV.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None of the authors has a financial or personal relationship with other people or organizations that could inappropriately influence (bias) their work, with the following exception: Dr. Eshleman has collaborated on research studies with Abbott Molecular; the company has provided reagents for research projects.

Similar articles

Cited by

References

    1. World Health Organization. Consolidated guidelines on HIV testing. 2015 Available at: http://who.int/hiv/pub/guidelines/hiv-testing-services/en/. Accessed: 1 November, 2017.
    1. Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory testing for the diagnosis of HIV infection: updated recommendations. 2014 Available at: http://dx.doi.org/10.15620/cdc.23447. Accessed: 1 November, 2017. - DOI
    1. Alexander TS. Human immunodeficiency virus diagnostic testing: 30 years of evolution. Clin Vaccine Immunol. 2016;23:249–53. - PMC - PubMed
    1. Rosenberg NE, Pilcher CD, Busch MP, Cohen MS. How can we better identify early HIV infections? Curr Opin HIV AIDS. 2015;10:61–8. - PMC - PubMed
    1. Cohen MS, Gay CL, Busch MP, Hecht FM. The detection of acute HIV infection. J Infect Dis. 2010;202(Suppl 2):S270–7. - PubMed

Publication types